Feng et al. [25] claimed that TNKS1 could regulate the Wnt/β-catenin signaling pathway positively during mouse embryonic development progression, indicating that downregulation of TNKS1 might suppress the Wnt/β-catenin signaling pathway in glioma cells. Here, TNKS is linked to central nervous system cancer.